Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. (Q37699439)
Jump to navigation
Jump to search
scientific article published on 04 February 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. |
scientific article published on 04 February 2014 |
Statements
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas (English)
Brigitte C Widemann
Eva Dombi
Andrea Gillespie
Pamela L Wolters
Jean Belasco
Stewart Goldman
Bruce R Korf
Jeffrey Solomon
Staci Martin
Wanda Salzer
Elizabeth Fox
Nicholas Patronas
John P Perentesis
Alyssa Reddy
John J Wright
AeRang Kim
Seth M Steinberg
1 reference
1 reference
1 reference